Robert Millar work email
- Valid
- Valid
- Valid
- Valid
Robert Millar personal email
Robert Millar phone numbers
I am currently focused on commercializing our EmphyCorp Rx N115 Non-Steroidal Nasal Spray w/ no adverse effects that has successfully completed Phase III Clinical Trials for Pulmonary Fibrosis and IPF, COVID-19, & Long COVID symptoms. See Rx N115 Nasal Spray Drug Pipeline. 3 New Composition Drug Patents for Hypoxemia (Low Oxygen)/Dyspnea (Shortness of Breath) and Apoptosis of Myofibroblasts (prevent more Scarring of the lungs) - 8 Drug Patents plus 1 Pending. North Cell Pharmaceutical has (3) New Drug Patents for OTC Skincare, Dermatology, Post Laser Aftercare, Eczema, Wound Care, Pet Product AND Rx Drug Pipeline - Eczema and Atopic Dermatitis Lotions, Topical Melanoma Lotion, Inoperable Tumors Injectable30 years successful corporate headquarters management experience with small and Fortune-size companies in global multiple sales distribution channel marketing, national account programs, strategic alliances/acquisitions, corporate communications, training, start-up operations, fund raising, meaningful use, electronic health records, new drug launch, and client support in several vertical markets. Created and executed marketing plans for companies in the Pharmaceutical/Biotech, enterprise software, SaaS Model Software/Services, collaboration software (integrated real-time, full motion broadcast quality video/VOIP Audio/content), HIPAA-Compliant Social and Business Networking Portal for Physicians, EHR Solutions, Voice-Recognition-to-Text Applications, ASP/network services, reconciliation systems, corporate actions software, medical services, web-based financial software, e-learning, live online CME/CEU Courses and events, internet services, banking software, network services, computer, office products, digital signage, and other vertical markets. NJ HITEC Field Agent; Meaningful Use Expert: Helped 400 Doctors and Dentists to meet Meaningful Use 2010 to 2017Board of Directors - Vemics Inc. 2003 to 2005Board of Directors - EmphyCorp Inc. 2010 to Present Successfully helped launch an OTC Nasal Spray in the US and China. E-mail: bobmillar@optonline.netTel: 973-586-4421Specialties: Pharmaceutical/Biotech OTC & Rx Drugs, enterprise software, Industry independent skill, visionary, global multiple sales distribution channel marketing/business development, vertical market knowledge, contract negotiations, national programs, strategic alliances/acquisitions, startups (pre-revenue to Fortune companies), business turnaround, public speaking, change management, collaboration technology, trade show expert, executive coaching/mentoring, fund raising.
Emphycorp Pharmaceutical & North Cell Pharmaceutical
-
President And DirectorEmphycorp Pharmaceutical & North Cell PharmaceuticalNew Jersey, United States
-
President & DirectorEmphycorp Pharmaceutical & North Cell Pharmaceutical Feb 2008 - PresentEmphyCorp is a privately owned NJ Biotech with several late stage Patented OTC and Rx Nasal and Lung Spray Drugs with no adverse effects. Our Rx N115 Non-Steroidal Nasal Spray with no adverse effects met 8 Medical Endpoints in 3 completed Phase III Clinical Trials for COVID-19, Long COVID and Pulmonary Fibrosis w/ COPD & IPF See Rx Pipeline. An Expanded Phase III Clinical Trial for IPF Coughing is completed. Announced an Expanded Phase III for Long COVID.North Cell Pharmaceutical (private) specializes in the development of Patented OTC products and Rx Drugs including Triple Antibiotics, Skincare, Eczema (including Atopic Dermatitis), Post Laser Aftercare, Pet products, and Topical/Injectables products for the treatment of Cancer and more. Responsible for product marketing, new OTC and Rx product launches, raising capital through Qualified Individual Investors, OTC Product Direct/Retail distribution, CE sponsorship, establishing Global Strategic Partnerships and Licensing/Option Agreements with Pharmaceutical companies, and Exit Strategy. EmphyCorp N115 Rx Nasal Spray Drug Product Pipeline (see Spreadsheet w/12 Drugs):• Rx N115 Non-Steroidal Nasal Spray with no known side effects with (8) U.S. Drug Patents has completed Phase III for Pulmonary Fibrosis, Long COVID, and COVID-19 Treatments.• N115 Nasal Spray Phase III Clinical Trial Results submitted to the US FDA and ready to seek FDA Approval of a New Drug Application for Pulmonary Fibrosis and IPF• Approved Nasal Spray was sold in China by an Affiliate in China Medical City (Over 3 million Patients treated in 100+ Chinese hospitals) • N115 has Orphan Drug Designation for Interstitial Lung Disease (Pulmonary Fibrosis, IPF, CF) • Phase III Ready for Unmet Needs (Diabetes, Hypertension, Pregnant Women, Small Children), COPD, Alzheimer’s, Concussions, Smoking Cessation (Oral), Cancer Pre-Treatment protecting non-cancerous cells before Chemo/Radiation Therapy (Johns Hopkins Phase II)
-
Cio And Svp Business DevelopmentImedicor, Inc. May 2005 - Feb 2017At iMedicor (formerly Vemics Inc.), was responsible for business development and sales in a start-up global hosted collaboration service solution company which became a public company in late 2005. Managed a Direct and Indirect Channel Sales Team focused on selling to several verticals markets including Fortune 500, Financial, Legal, Corporate Training, Education, EMR Solutions Consulting, Allied Health, Medical Services, Pharmaceutical, Government, and Small Business. At iMedicor and Vemics Inc. I helped fund raising effort by making introductions to corporate strategic investors, venture firms, and private equity firms. NJ HITEC Field Agent 2010 to 2015Member of the Vemics Inc. Board of Directors 2003 to 2005iMedicor (formerly Vemics Inc.) Website: www.iMedicor.com iMedicor was the 1st HIPAA-Compliant Portal for Physicians that has a HIPAA-Compliant Transport, allows Physicians to send Disparate Electronic Medical Records and Digital MRIs, X-Rays, etc. to referring Physicians and Healthcare Providers; ClearLobby Service that permits Pharmaceutical Firms and Medical Device Manufacturers to reach Physicians with new products, clinical information, order drug samples, set-up appointment with Pharma Rep Calendar, and much more.
-
Svp - New Vertical MarketsSmartstream Technologies Inc. Feb 2003 - Jul 2005London, England, GbResponsible for a start-up new verticals marketing operation for the global market share leaders in reconciliation systems. Target and manage all strategic partnerships such as Sun Microsystems, strategic industry software and services partners, and two long-term strategic clients (Fidelity and CIBC Toronto). New Vertical Markets include: marketing reconciliation, process automation, and corporate actions software to the Insurance, Financial, TELCO, State and Federal Government, Manufacturing, Computer, Software, and 3rd-party services companies.Website: www.smartstream-stp.com -
Vice President – Alliances & MarketingZoologic, Inc. (An Ss&C Company) Feb 2001 - Sep 2002Responsible for Marketing & Indirect Sales Channels for the worldwide leader in online browser- based courses for finance professionals. Developed strategic sales and marketing plans to increase global market share in the financial industry. Successfully managed corporate communications and introduced a new “Best of Breed” Channel Partner Program. A few of the strategic alliances signed include IBM Mindspan, Intellinex (Ernst & Young), Adkins, Matchett & Toy, Fathom, TAC CO.LTD, Educacorp, DeSai Systems, and other companies around the world. Website: www.zoologic.com
-
Vice President – Marketing & Channel SalesCoriss.Net, Inc. Nov 1999 - Dec 2000Responsible for the Global Sales and Marketing for an Internet collaboration software start-up company. Successfully introduced the CorissLine™ software that enables Internet-based meetings, virtual offices, interactive decision-making, and more with fully interactive, template-driven Internet collaboration (voice/data/graphics/real-time video) technology. Several Channel Partners including Programmer’s Paradise, Engineering Systems Solutions, GearBoxx, The Compuflex Corporation, and W.F. Murray Associates marketed the CorissLine software and CorissLink™ turnkey solution. Coriss.Net closed and donated the IP Assets to Capitol College, who used the CorissLine software for Distance Learning.
-
Vice President/Director - Global Partnership Sales & MarketingCsi Complex Systems, Inc. Jan 1997 - Nov 1999Responsible for Global Sales and Marketing of the number one banking international trade finance software, TradePaq www.tradepaq.com corporate import/export software, internet based trade services, systems integration services, and ResQNet.com www.resqnet.com GUI products through Strategic Partnerships. The position reported directly to the President/COO and resulted in immediate business with several partners. The following strategic partners joined the start-up Global Partnership Program: Hewlett Packard, Sun Microsystems, IBM, NCR, Fiserv, Financial Network Services (Australia), TeraSystems (Phillipines), The LoBue Group , Ark Infoware (Singapore), Alliance Factors (Moscow), Professional Computing (Malta), Software Alliance Malaysia, Astra Graphia (Indonesia), SWIFT, International Turnkey Systems (Kuwait), and Microsoft.CSI Complex Systems Website: www.banktrade.com ResQNet Website: www.resqnet.comTradePaq Website: www.tradepaq.com
-
Vice President - Indirect SalesAts Money Systems, Inc. (A De La Rue Company) Jan 1992 - Dec 1996Responsible for Global Sales and Marketing with Strategic Alliances, Vars, and Dealers. Products included DOS and UNIX based Retail Store Cash Office Reconciliation systems, Deposit Processing Systems, Bank ATM settlement systems, Food Stamp Processing Systems, Armored Car Deposit Processing Systems, Teller Terminals, Teller Assist Cash Dispensers, Currency Counters, Coin Counters, MICR Encoders, and Network Software.• Developed a start-up Global Indirect sales and Marketing Program.• Formed Alliances with Standard Register, NCR, Unisys, SCO, and MidSouth Data Systems.• Partnered with NCR and won a Global Bid for providing Unix-based Reconciliation Systems to NEXCOM (Navy Exchange and other Retail Stores on Navy bases)• Turned (2) Years of company losses into record profits ($.18 Earnings Per Share).DeLaRue Website: www.delarue.com
-
Manager, Global Edi Alliance ProgramsGeneral Electric Information Services (Geis) - (Became Global Exchange Services) Feb 1990 - Oct 1991Responsible for managing the worldwide marketing of Electronic Data Interchange (EDI) mainframe / P.C. based application software and global teleprocessing network services through computer manufacturers and software Vars. The start-up EDI Alliance Marketing and Sales Program had a 5% annual growth rate.Website: www.gxs.com
-
Industry Marketing/Support Manager – Sharp National Account Program (Snap)Sharp Electronics Corporation Dec 1983 - Feb 1990Montvale, Nj, UsIndustry Marketing/Support Manager – Sharp National Account Program (SNAP)• Responsible for a start-up National Account Marketing Program selling Copiers, Fax, Calculators, Computers, Software, Color Scanners, Laser Printers, Retail POS, Registers, Bank Teller Terminals, MICR Encoders, and Office Equipment. • Sales reached $ 35 Million within the first (18) months.Marketing Manager - Financial Systems• Responsible for all phases of marketing Teller Terminals and MICR Encoders to the Retail, Banking, Government, and Commercial Vertical Markets. • Successfully introduced Sharp’s first-ever Online Teller Terminal and MICR Encoder Products.• Sharp BE-2500 Series Teller Machines reached number one in market share within (2) years. Eastern Regional Sales Manager/U.S. System Integrator Manager• Managed (8) Regional Salespersons in a startup VAR/Systems Integrator Program.• Wrote the specifications for the Sharp offline/online Teller Terminal and MICR Encoder. -
Management ConsultantNational Unlimited Business Systems Oct 1982 - Nov 1983Opened a start-up Philadelphia office that sold over $1 Million in banking products in (1) year.
-
Financial Systems Account ManagerNcr Corporation Sep 1979 - Oct 1982Atlanta, Georgia, UsSold Computer Systems, Teller Terminals, ATM’s, and Item Processing Systems to Banks.Website: www.ncr.com
Robert Millar Skills
Robert Millar Education Details
-
Rutgers UniversityBusiness Administration -
Rider UniversityManagement
Frequently Asked Questions about Robert Millar
What company does Robert Millar work for?
Robert Millar works for Emphycorp Pharmaceutical & North Cell Pharmaceutical
What is Robert Millar's role at the current company?
Robert Millar's current role is President and Director.
What is Robert Millar's email address?
Robert Millar's email address is bo****@****ine.net
What is Robert Millar's direct phone number?
Robert Millar's direct phone number is +184537*****
What schools did Robert Millar attend?
Robert Millar attended Rutgers University, Rider University.
What are some of Robert Millar's interests?
Robert Millar has interest in Usotb, Listening To All Types Of Music, Civil Rights And Social Action, Plays Guitar And Writes Songs, Basketball, Msbl, Plays Baseball, Golf, Health.
What skills is Robert Millar known for?
Robert Millar has skills like Enterprise Software, Fundraising, Trade Shows, Contract Negotiations, Public Speaking, Meaningful Use, Hipaa, Otc Drugs, Global Partnerships, Deal Structure, Execution Skills, Ehr.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial